Denada Dangaj

[Denada Dangaj @DangajD]

I am delighted to be presenting at the 2023 Ovarian Cancer Australia Symposium for health professionals in Sydney on the 5th of May. I will be presenting on “ Heterogeneity and Immunobiology of High-Grade Serous Ovarian Cancer”. 

To register, see the li…https://t.co/4VCWE5Z157

[Denada Dangaj @DangajD]

https://t.co/3OlcFY6Hyk https://t.co/JDprZEOii3

[Denada Dangaj @DangajD]

https://t.co/H6l46LZIkj https://t.co/qhZdZNN0Ha

[Denada Dangaj @DangajD]

Genetics and anatomy sculpt immune-cell partners of ovarian cancer https://t.co/2ubEdPUFp6
@CoukosGeorge

[Denada Dangaj @DangajD]

On behalf of all coauthors, I am happy to share our recent pre-print with the community. https://t.co/xMjRgmk6ob

[Denada Dangaj @DangajD]

@biorxiv_immuno On behalf of all coauthors, I am happy to share our recent pre-print with the community
@CoukosGeorge @EleonoraGhisoni @DangajD @AlexandreHarari @MMorotti

[bioRxiv Immunology @biorxiv_immuno]

Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma https://t.co/c0aRPF9JT1 #biorxiv_immuno

[Oncology UNIL CHUV @OncoUNILCHUV]

Just out in @NatureNV, @CoukosGeorge and Denarda Dangaj Laniti consider how data that reveal cellular, molecular and mutational landscape, as ovarian cancer tumours grow and spread, might aid efforts to develop new targeted therapies.

@unil @chuv @Ludwig_Cancer

[Oncology UNIL CHUV @OncoUNILCHUV]

𝘑𝘜𝘚𝘛 𝘖𝘜𝘛: REVIEW of immunobiology of HGSOC.
🔖TILs
🔖Opportunities for immunotherapy

📑https://t.co/ylB10Err82

By Lana Kandalaft, Denarda Dangaj & @CoukosGeorge.

#CancerResearch @unil @CHUVLausanne @Ludwig_Cancer.